Lineage Cell Therapeutics, Inc. Deposits Assets, Noncurrent
Lineage Cell Therapeutics, Inc. (LCTX) had Deposits Assets, Noncurrent of $552.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DepositsAssetsNoncurrent · last filed 2023-11-09
- 2023-09-30: Deposits Assets, Noncurrent $552.00K.
- 2023-06-30: Deposits Assets, Noncurrent $588.00K.
- 2023-03-31: Deposits Assets, Noncurrent $635.00K.
- 2022-12-31: Deposits Assets, Noncurrent $627.00K.
| Period end | Deposits Assets, Noncurrent | Deposits Assets, Noncurrent as first filed |
|---|---|---|
| 2023-09-30 | $552.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $588.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $635.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $627.00K 10-Q · filed 2023-11-09 | |
| 2022-09-30 | $591.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $598.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $639.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $630.00K 10-K · filed 2023-03-09 | |
| 2021-09-30 | $614.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $610.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $601.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $616.00K 10-K · filed 2022-03-10 | |
| 2020-09-30 | $666.00K 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $649.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $637.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $864.00K 10-K · filed 2021-03-11 | |
| 2019-09-30 | $826.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $815.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $890.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $505.00K 10-K · filed 2020-03-12 | |
| 2018-09-30 | $518.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $229.00K 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $236.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $1.02M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $1.00M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.01M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $977.00K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $1.15M 10-K · filed 2018-03-15 | $1.03M 10-K · filed 2017-03-16 |
| 2016-09-30 | $1.01M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $1.02M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $1.27M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $1.30M 10-K · filed 2017-03-16 | |
| 2015-06-30 | $446.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $443.00K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $453.00K 10-K · filed 2016-03-15 | $443.29K 10-K · filed 2015-03-11 |
| 2014-09-30 | $435.32K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $435.48K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $428.83K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $129.13K 10-K · filed 2015-03-11 | |
| 2013-09-30 | $126.15K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $118.58K 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $118.75K 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $64.44K 10-K · filed 2014-03-17 | |
| 2012-09-30 | $67.89K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $67.39K 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $63.96K 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $63.08K 10-K · filed 2013-03-18 | |
| 2011-09-30 | $65.26K 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $65.89K 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $51.90K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |